Patents
Patents for C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897)
05/2005
05/31/2005US6900193 Urogential disorders; antitumor agents; hormone inhibitor
05/26/2005WO2005009361A3 Method of treating hit patients with argatroban
05/26/2005US20050113316 Process for producing dammarane sapogenins and ginsenosides
05/25/2005CN1620303A Skin perparation for external use containing purpuricenus temminckii frass as the active ingredient
05/24/2005US6897298 Method for extracting a compound from a ginseng spp. plant, ginseng or pseudo-ginseng
05/24/2005US6896911 Saponification, dehydration, leaching
05/19/2005US20050107582 Preparing phytosterols from tall oil pitch comprising converting steryl esters to free phytosterols, remove light ends from modified pitch by evaporation, evaporate bottom fraction to produce light phase distillate, dissolve light phase distillate in solvent, cool slurry, recover crystallized phytosterol
05/19/2005US20050107337 Platinum complexes having antitumor activity
05/18/2005CN1616479A Method for extracting stigmasterol from plant sterol
05/18/2005CN1202119C Hemsleyadine derivative and its preparing method and use as bactericidal agent
05/17/2005CA2248950C Process for hydrogenating unsaturated plant-based compounds and regeneration of a used catalyst
05/17/2005CA2057099C Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
05/12/2005US20050101573 Meiosis regulating compounds
05/11/2005EP1210359B1 A process for the preparation of 3-amino bile acid derivatives
05/11/2005CN1613866A Preparation of gynostemma pentaphylla saponin
05/11/2005CN1200916C Preparation method of total saponin and flavone extract in notoginseng leaf
05/04/2005CN1611510A Process for extracting saponin from pseudo-ginseng stem-leaf-flower
05/03/2005US6888014 Dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
04/2005
04/28/2005US20050090663 Carbonylation; hydrogenation; epoxidation; alkynylation; for preparation of eplerenone
04/28/2005US20050090477 Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-halogen steroids that can be produced therefrom, their process for production and use as well as pharmaceutical prepartions that contain these compounds, as well as 7-substituted estra-1,3,5(10)-trienses that can be produced therefrom
04/26/2005US6884796 Useful for relieving infertility in females and males
04/26/2005CA2123052C Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
04/21/2005US20050085557 Oxidation of cholesterol in atherosclerosis plaque; cytotoxic
04/21/2005US20050085556 Generated by atherosclerosis plaque; contacting with antibody; measurement; calibration
04/21/2005US20050085539 Method of reducing toxicity of retinoids
04/21/2005US20050085451 Interference with absorption of cholesterol using synergistic mixture of fatty acid and sterol ; side effect reduction
04/20/2005EP1523568A2 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
04/19/2005US6881730 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
04/14/2005US20050080064 Steroids as agonists for fxr
04/14/2005US20050079258 Phytosterol compositions
04/14/2005US20050079233 Using plant extracts
04/06/2005EP0663013B1 Method for delivering nucleic acids into cells
04/05/2005CA2175906C Conversion of bisnoralcohol to bisnoraldehyde
03/2005
03/31/2005WO2002042319A9 2-substituted estrogens as antiangiogenic agents
03/30/2005EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia
03/24/2005WO2005026189A1 Process for the recovery of a phytolipid composition
03/17/2005WO2005023832A1 Compound and method for enhancing the cholesterol lowering property of plant sterol and stanol esters
03/17/2005WO2005023831A1 Detection of cholesterol ozonation products
03/17/2005WO2005023830A2 Ozonation products of cholesterol for the treatment and prevention of atherosclerosis and/or cardiovascular diseases
03/17/2005WO2005007669A8 Novel fusidic acid derivatives
03/17/2005CA2537984A1 Detection of cholesterol ozonation products
03/17/2005CA2537976A1 Ozonation products of cholesterol for the treatment and prevention of artherosclerosis and/or cardiovascular diseases
03/17/2005CA2537744A1 Compound and method for enhancing the cholesterol lowering property of plant sterol and stanol esters
03/16/2005CN1594351A Method for preparing sitostamol
03/16/2005CN1594350A Method for separating and extracting cholesterol from lanolin
03/10/2005US20050054621 Fractionation of phytosterol esters in oil
03/10/2005US20050053712 Process for the recovery of a phytolipid composition
03/10/2005US20050051419 Recovering a phytolipid from a vegetable oil by-product by distillation, the product comprising squalene, phytosterols, mixed tocopherols and tocotrieneols, and vegetable wax; useful as an emollient and also may be incorporated into foods, beverages, and nutraceuticals
03/09/2005CN1192034C Process for producing diels-alder adducts of sterol 5,7-dienes using unsaturated fatty acid catalyst
03/08/2005US6864394 Method for producing ketones from carboxylic acid anhydrides
03/08/2005CA2246017C Stanol comprising compositions
03/02/2005CN1587273A Process for synthesizing 20(S)-ginsenoside Rh2
03/01/2005US6861415 Antagonize endogenous progesterone to induce menses or labor, treat endometriosis, dysmenorrhea; endocrine hormone-dependent tumors, and uterine fibroids, inhibit uterine endometrial proliferation and for contraception
02/2005
02/23/2005CN1585777A 肝脏x受体激动剂 Liver x receptor agonist
02/23/2005CN1583782A Synthesis of 24-submethyl-cholesterol-5-ene-3 beta, 7 beta, 19-trialcohol
02/23/2005CN1583781A Synthesis of 3 beta, 7 beta, 19-tricarboxy-5-ene-cholestane
02/23/2005CN1583780A Method for preparing high-content beta-sitosterin products by catalytic hydrogenation
02/23/2005CN1190199C Medicinal use and prepn. process of general ketosteroid of Tinospora Hainanesis
02/22/2005US6858226 Fusogenic lipids and vesicles
02/17/2005US20050038301 Producing vicinal diols; reacting with hydroxyl group donor and reducing acidic agent
02/17/2005US20050038270 Methods for producing sterol ester-rich compositions
02/17/2005US20050037028 Topical antiallergenic cream containing Asian longhorn beetle wastes; animal extracts
02/16/2005CN1582153A Use of (11beta, 17beta)-11-(1, 3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4, 9-dien-3-one in the treatment of major depressive disorder
02/15/2005US6855837 Process for the preparation of stanol esters
02/15/2005CA2124339C Novel 19-nor steroids having a thiocarbon-containing chain in the 11 beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositionscontaining said steroids
02/10/2005US20050033068 Process for the purification of sterols from hydrocarbon extracts using evaporative fractionation
02/10/2005US20050032765 Steroid derived antibiotics
02/10/2005DE19845403B4 Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung With bile acids linked Propanolaminderivate, processes for their preparation, pharmaceutical compositions containing them and their use
02/09/2005EP1504019A1 Platinum complexes having antitumor activity
02/09/2005CN1578497A Radio base station, radio communication system, communication control method of cell station
02/08/2005US6852670 Method for manufacturing anion-layered double hydroxide intercalation compounds and compounds produced thereby
02/03/2005WO2005009361A2 Method of treating hit patients with argatroban
02/03/2005WO2004111073A3 Sterol recovering method
02/03/2005US20050026885 Administering during follicular phase in a dosage less than an ovulation-inhibiting or abortion-inductive dose; 11 beta -[(4-N,N-Dimethylamino) -phenyl]-17 beta -hydroxy-17 alpha -propinyl-4,9(10)-estradien-3-one (RU 38486) for example; will not abort previously implanted fetus
02/02/2005CN1187364C 类固醇衍生物 Steroid derivatives
01/2005
01/27/2005WO2005007669A1 Novel fusidic acid derivatives
01/27/2005CA2532725A1 Novel fusidic acid derivatives
01/26/2005CN1569882A Process for preparing protopanoxadiol and protopanaxatriol
01/20/2005WO2005005453A2 Novel compounds and compositions comprising sterols and/or stanols and cholesterol biosynthesis inhibitors and use thereof in treating or preventing a variety of diseases and conditions.
01/20/2005CA2531836A1 Novel compounds and compositions comprising sterols and/or stanols and cholesterol biosynthesis inhibitors and use thereof in treating or preventing a variety of diseases and conditions.
01/19/2005EP1496913A2 Neuroprotective spirostenol pharmaceutical compositions
01/19/2005CN1566135A Preparation process for ginsenoside Rb1
01/13/2005US20050010061 Process for the isolation of sterols and/or wax alcohols from tall oil products
01/13/2005US20050009794 Crystals of a vitamin D derivative and a method for the preparation thereof
01/12/2005EP1495042A1 Blanched polyamine steroid derivatives
01/12/2005EP1494691A2 Treatment of diseases involving defective gap junctional communication
01/12/2005EP1494533A2 Farnesoid x-activated receptor agonists
01/12/2005CN1563072A Method for extracting fucosterol from alga
01/06/2005WO2005000866A1 Cyclopentaperhydro-phenathrene 3-beta-carboxylic acid salts useful as emulsifier
01/06/2005US20050004382 Meiosis regulating compounds
12/2004
12/30/2004US20040267032 Process for recovering value-added products from pulping soap
12/30/2004US20040266863 Use of (11beta,17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder
12/30/2004US20040264421 Cell station, radio communication system, communication control method of cell station, and method of building radio communication network
12/29/2004WO2004064743A3 Modified retinoid compounds and their uses
12/29/2004EP1225902B1 Ciclesonide contained pharmaceutical composition for application to mucosa
12/29/2004CN1558766A A method of reducing the 'in vivo' cholesterol ester transfer protein mediated transfer of cholesteryl esters between high density lipoproteins (HDL) and low density lipoproteins (LDL)
12/29/2004CN1557830A Process for preparing 20(R)-ginsenoside Rh2
12/25/2004CA2433246A1 Process for recovering value-added products from pulping soap
12/23/2004WO2004111073A2 Sterol recovering method
12/23/2004US20040260104 Filtering, washing and drying from mixtures with fatty esters of rape oil or soybean oil, and methanol; improved simplicity and efficiency; anticholesterol agents
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 49